| Literature DB >> 29198180 |
Shaun L Barnabas1,2, Smritee Dabee1, Jo-Ann S Passmore1,3,4, Heather B Jaspan1,5, David A Lewis6,7,8, Shameem Z Jaumdally1,4, Hoyam Gamieldien1,3, Lindi Masson1,3, Etienne Muller8, Venessa D Maseko8, Nonhlanhla Mkhize8, Zizipho Mbulawa1,3, Anna-Lise Williamson1,3,9, Clive M Gray1,3, Thomas J Hope10, Francesca Chiodi11, Janan Dietrich12, Glenda Gray12,13, Linda-Gail Bekker1,2.
Abstract
Adolescents in Africa are at high risk for HIV infection, other sexually transmitted infections (STIs) and bacterial vaginosis (BV). Since behavior and burden of STIs/BV may influence HIV risk, behavioral risk factors and prevalence of STIs/BV were compared in HIV-seronegative adolescent females (n = 298; 16-22 years) from two South African communities (Soweto and Cape Town). STIs ( Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex virus (HSV)-1, HSV-2, Treponema pallidum, and Haemophilus ducreyi) were detected by multiplex polymerase chain reaction, human papillomavirus (HPV) by Roche Linear Array, and BV by Nugent scoring. Rates of BV (Nugent ≥7; 46.6%) and HPV (66.8%) were high in both communities. Prevalence of C. trachomatis and N. gonorrhoeae were >2-fold higher in Cape Town than Soweto (Chlamydia: 42% [62/149] versus 18% [26/148], p < 0.0001; gonorrhoea 11% [17/149] versus 5% [7/148], p = 0.05). Only 24% of adolescents with vaginal discharge-causing STIs or BV were symptomatic. In South African adolescents, clinical symptoms compatible with vaginal discharge syndrome had a sensitivity of 23% and specificity of 85% for the diagnosis of discharge-causing STI or BV. In a region with high HIV prevalence and incidence, >70% of young women with treatable conditions that could enhance HIV risk would have been missed because they lacked symptoms associated with syndromic management.Entities:
Keywords: Female; adolescents; bacterial vaginosis; sexually transmitted infections; syndromic management
Mesh:
Year: 2017 PMID: 29198180 DOI: 10.1177/0956462417740487
Source DB: PubMed Journal: Int J STD AIDS ISSN: 0956-4624 Impact factor: 1.359